<p>Lysosomal storage diseases (LSDs) are devastating neurological disorders caused by mutations in lysosomal hydrolases that result in accumulations of hydrolase substrates. Tay-Sachs disease (TSD) is an LSD that specifically results in the accumulation of GM2 gangliosides causing the activation of inflammatory signaling pathways, and leading to microglial activation and apoptotic cell death. The detailed mechanisms through which cell death occurs have not been completely elucidated, however, excitotoxicity is thought to play a major role. Here, we investigated the role of hypoxia-inducible factor-1α (HIF- 1α) and its effector microRNA, miR-210, and the impact they have on the expression of important molecules involved in excitotoxicity, namely neuronal pentraxin 1 (NPTX1) and potassium channel KCNK2 (KCNK2). We discovered that TSD neuroglia are inefficient at stabilizing HIF-1α in hypoxic conditions. Furthermore, miR-210 expression is significantly higher in TSD neuroglia compared to normal neuroglia at baseline and during hypoxia. In addition, TSD neuroglia expressed <em>NPTX1</em>, <em>NPTX2 </em>and <em>KCNK2 </em>at higher levels, and neuronal pentraxin receptor at lower levels than normal neuroglia, implicating excitotoxicity in disease pathogenesis. We also confirmed that miR-210 binds to the 3’ UTR of <em>NPTX1 </em>to repress its expression in TSD neuroglia. The presence of reverse hypoxia response elements in the promoter of KCNK2 and the repression of <em>KCNK2 </em>expression by HIF-1α stabilization suggest that KCNK2 is directly regulated by HIF-1α. Moreover, the glucosylceramide synthase inhibitor, NBDNJ, which is used to reduce ganglioside synthesis, caused expression of <em>NPTX1 </em>to decrease but <em>KCNK2 </em>expression to increase, indicating this drug can modify multiple parameters of disease. This study identifies major gene expression changes between normal and TSD neuroglia that affect the excitability and therefore the viability of TSD cells. This information provides new insight into the mechanisms of neurodegeneration experienced by TSD neuroglia.</p> / Master of Science (MSc)

Introdução: Penfigoide bolhoso (PB) resulta da produção de autoanticorpos contra proteínas hemidesmossomais BP (Bullous Pemphigoid) 180 e/ou 230, acomete os idosos, e está associado com doenças neurológicas (DN), especialmente com a demência (DEM). BP180/230 foram identificadas no Sistema Nervoso Central (SNC), aventando-se possível mimetismo antigênico entre moléculas da pele e do SNC. O fator neurotrófico derivado do cérebro (BDNF) participa da neurogênese, sinaptogênese e sobrevivência neuronal, e a sua diminuição sérica tem sido relacionada com DN. Objetivo: Quantificar o peptídeo BDNF e os anticorpos anti-BP180/230 na relação PB com DEM. Material e Métodos: Em estudo comparativo, 50 pacientes com PB, 50 com demência e 50 controles foram avaliados. A detecção dos anticorpos anti-BP180/P230 e do peptídeo BDNF foi determinada por ensaios ELISA. Imunofluorescência indireta (IFI) foi conduzida nas amostras de soro dos pacientes do grupo DEM e dos controles que apresentaram positividade para anti-BP180/230. Resultados: No grupo PB, a frequência de DN foi de 26%: DEM 16%, acidente vascular cerebral 6%, e epilepsia 4% - 5/8 (63%) pacientes apresentaram demência vascular e 3/8 (38%) demência por doença de Alzheimer. Positividade para anti-BP180/230 foi observada no grupo PB (74% e 40%, respectivamente), no grupo DEM (10% e 10%) e nos controles (14% e 0%). No grupo DEM, em 2/10 pacientes que apresentaram positividade para antiBP180/230, a IFI evidenciou depósito de IgG e C3 no lado epidérmico da clivagem, configurando quadro subclínico de PB. A mediana do BDNF resultou menor no grupo DEM (25,41 pg/ml) comparado aos controles (38,21 pg/mL), e o grupo PB apresentou os menores valores de BDNF (16,88 pg/mL). Não houve correlação dos títulos de anticorpos antiPB180/230 com a concentração do peptídeo BDNF no grupo PB. Os pacientes do grupo DEM foram alocados de acordo com a escala de demência - CDR1, CDR2 e CDR3; a mediana de BDNF do subgrupo CDR3 (23,37 pg/mL) foi inferior ao CDR1 (30,17 pg/ mL). Não houve diferença na concentração do BDNF segundo o tipo de demência. O grupo PB, quando estratificado em - com DEM, outras DN e sem DN, aqueles com associação com DEM apresentaram menores níveis de BDNF (9,1 pg/mL), comparados ao grupo sem DN e ao subgrupo CDR3 do grupo DEM. Conclusão: Marcadores para PB não são úteis para o diagnóstico de DEM. Valores sorológicos baixos de BDNF no grupo PB podem sugerir associação com DEM. BDNF pode ser utilizado como biomarcador de gravidade da DEM. / Introduction: Bullous pemphigoid (BP) is characterized by autoantibodies against the hemidesmossomal proteins BP180 and/or BP230, affects the elderly people and has been strongly associated with neurological disorders (ND), especially dementia. A possible antigenic mimicry hypothesis between the skin and the nervous system molecules is strong reasonable because BP peptides have also been identified in the central nervous system (CNS). Brain-derived neurotrophic factor (BDNF) plays a role in the synaptogenesis, neurogenesis, and neuronal survival, and some studies have been correlated the decreased serum BDNF levels with ND. The aim of this study was to quantify the BDNF peptide and the anti-BP180 and anti-BP230 antibodies in the BP and DEM relationship. Methods: AntiBP180/230 and BDNF quantification were analyzed in three groups: 50 patients with BP, 50 patients with dementia and 50 elderly individuals comprised a case-control study. Serum IgG anti-180/230, and the BDNF peptide were evaluated by using ELISA commercial kits; and immunofluorescence allied to salt split skin technique (SSS) was conducted in serum samples from patients of the dementia group and from controls who showed positive anti-BP180/230. Results: In BP group, 26% were associated with ND, and dementia was the most frequent (16%), followed by stroke (6%) and epilepsy (4%) - 5/8 (63%) patients showed vascular dementia and 3/8 (38%) patients presented dementia due to Alzheimer\'s disease. AntiBP180/230 positivity was observed in BP group (74%, 40%, respectively), in dementia group (10%, 10%) and in controls (14%, 0%). In 2/10 patients of the dementia group with positive anti-BP180/230, IIF showed IgG and C3 deposition in the epidermal side of cleavage, configuring a subclinical BP dermatosis. The medians of BDNF resulted lower in the patients of the dementia group (25.41 pg/mL) compared with controls (38.21 pg/mL), and the BP group presented the lowest BDNF values (16.88 pg/mL). There was no correlation between the anti-BP180/230 antibodies titres and the BDNF levels in BP group. There was no difference of BDNF levels accordingly with the clinical type of dementia in the dementia group. Patients of the dementia group were sub grouped accordingly with the clinical dementia severity - CDR1, CDR2 and CDR3 - being the median of BDNF in CDR3 (23.37 pg/mL) lower than in CDR1 (30.17 pg/mL) subgroup. BP group had lower levels of BDNF compared to CDR3 subgroup. BP patients when stratified with dementia, other ND and without ND, those with association with dementia presented the lowest levels of BDNF (9.1 pg/mL) compared to the PB patients without DN and to the CDR3 subgroup. Conclusion: BP biomarkers are not useful for the diagnosis of dementia. Low BDNF levels seen in BP patients may suggest an association with dementia. BDNF may be used as a biomarker of severity of dementia.

The human brain (lat. cerebrum) is the most complex and heterogeneous organ in the human body. It is involved in a great number of body functions like movement, touch sensing, vision, hearing, smelling, hormone regulation and many more. In no other organ, the molecular communication mechanisms between different cells are so poorly understood. Due to the extensive diversity of processes that are controlled by the brain, diseases and injuries of the nervous system affect the human body significantly. Because of the immense complexity of the brain, the molecular mechanisms underlying the pathology of the diseases remain largely unknown. Hence, there is an urgent need for the development of new analytical strategies in order to investigate these conditions on a molecular level. Here, a central focus lies in the study of protein and peptide expression profiles, which can provide an insight in ongoing molecular mechanisms underlying the pathophysiology of the diseases. A powerful approach for studying proteins and peptide dynamics is mass spectrometry based proteomics, which is defined as the comprehensive study of all proteins expressed in a biological matrix at a certain point of time. The central objective of this thesis was to develop and employ different mass spectrometric techniques to study protein and peptide dynamics in the central nervous system in different neurological diseases. The individual studies comprise different aspects of proteome research. The first two studies included clinical proteomic applications for investigating protein dynamics in traumatic brain injury and amyotrophic lateral sclerosis. A further study was focused on method development for MS analysis of intact neural cells. The final three projects described in this thesis comprised MS based protein and peptide imaging in brain and spinal cord tissue samples. Here, the aim was to elucidate topological changes in protein expression in ALS as well as neuropeptide alterations in distinct brain structures in L-DOPA induced dyskinesia (LID) in Parkinson’s disease. / Felaktigt tryckt som Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 713

Introdução: Penfigoide bolhoso (PB) resulta da produção de autoanticorpos contra proteínas hemidesmossomais BP (Bullous Pemphigoid) 180 e/ou 230, acomete os idosos, e está associado com doenças neurológicas (DN), especialmente com a demência (DEM). BP180/230 foram identificadas no Sistema Nervoso Central (SNC), aventando-se possível mimetismo antigênico entre moléculas da pele e do SNC. O fator neurotrófico derivado do cérebro (BDNF) participa da neurogênese, sinaptogênese e sobrevivência neuronal, e a sua diminuição sérica tem sido relacionada com DN. Objetivo: Quantificar o peptídeo BDNF e os anticorpos anti-BP180/230 na relação PB com DEM. Material e Métodos: Em estudo comparativo, 50 pacientes com PB, 50 com demência e 50 controles foram avaliados. A detecção dos anticorpos anti-BP180/P230 e do peptídeo BDNF foi determinada por ensaios ELISA. Imunofluorescência indireta (IFI) foi conduzida nas amostras de soro dos pacientes do grupo DEM e dos controles que apresentaram positividade para anti-BP180/230. Resultados: No grupo PB, a frequência de DN foi de 26%: DEM 16%, acidente vascular cerebral 6%, e epilepsia 4% - 5/8 (63%) pacientes apresentaram demência vascular e 3/8 (38%) demência por doença de Alzheimer. Positividade para anti-BP180/230 foi observada no grupo PB (74% e 40%, respectivamente), no grupo DEM (10% e 10%) e nos controles (14% e 0%). No grupo DEM, em 2/10 pacientes que apresentaram positividade para antiBP180/230, a IFI evidenciou depósito de IgG e C3 no lado epidérmico da clivagem, configurando quadro subclínico de PB. A mediana do BDNF resultou menor no grupo DEM (25,41 pg/ml) comparado aos controles (38,21 pg/mL), e o grupo PB apresentou os menores valores de BDNF (16,88 pg/mL). Não houve correlação dos títulos de anticorpos antiPB180/230 com a concentração do peptídeo BDNF no grupo PB. Os pacientes do grupo DEM foram alocados de acordo com a escala de demência - CDR1, CDR2 e CDR3; a mediana de BDNF do subgrupo CDR3 (23,37 pg/mL) foi inferior ao CDR1 (30,17 pg/ mL). Não houve diferença na concentração do BDNF segundo o tipo de demência. O grupo PB, quando estratificado em - com DEM, outras DN e sem DN, aqueles com associação com DEM apresentaram menores níveis de BDNF (9,1 pg/mL), comparados ao grupo sem DN e ao subgrupo CDR3 do grupo DEM. Conclusão: Marcadores para PB não são úteis para o diagnóstico de DEM. Valores sorológicos baixos de BDNF no grupo PB podem sugerir associação com DEM. BDNF pode ser utilizado como biomarcador de gravidade da DEM. / Introduction: Bullous pemphigoid (BP) is characterized by autoantibodies against the hemidesmossomal proteins BP180 and/or BP230, affects the elderly people and has been strongly associated with neurological disorders (ND), especially dementia. A possible antigenic mimicry hypothesis between the skin and the nervous system molecules is strong reasonable because BP peptides have also been identified in the central nervous system (CNS). Brain-derived neurotrophic factor (BDNF) plays a role in the synaptogenesis, neurogenesis, and neuronal survival, and some studies have been correlated the decreased serum BDNF levels with ND. The aim of this study was to quantify the BDNF peptide and the anti-BP180 and anti-BP230 antibodies in the BP and DEM relationship. Methods: AntiBP180/230 and BDNF quantification were analyzed in three groups: 50 patients with BP, 50 patients with dementia and 50 elderly individuals comprised a case-control study. Serum IgG anti-180/230, and the BDNF peptide were evaluated by using ELISA commercial kits; and immunofluorescence allied to salt split skin technique (SSS) was conducted in serum samples from patients of the dementia group and from controls who showed positive anti-BP180/230. Results: In BP group, 26% were associated with ND, and dementia was the most frequent (16%), followed by stroke (6%) and epilepsy (4%) - 5/8 (63%) patients showed vascular dementia and 3/8 (38%) patients presented dementia due to Alzheimer\'s disease. AntiBP180/230 positivity was observed in BP group (74%, 40%, respectively), in dementia group (10%, 10%) and in controls (14%, 0%). In 2/10 patients of the dementia group with positive anti-BP180/230, IIF showed IgG and C3 deposition in the epidermal side of cleavage, configuring a subclinical BP dermatosis. The medians of BDNF resulted lower in the patients of the dementia group (25.41 pg/mL) compared with controls (38.21 pg/mL), and the BP group presented the lowest BDNF values (16.88 pg/mL). There was no correlation between the anti-BP180/230 antibodies titres and the BDNF levels in BP group. There was no difference of BDNF levels accordingly with the clinical type of dementia in the dementia group. Patients of the dementia group were sub grouped accordingly with the clinical dementia severity - CDR1, CDR2 and CDR3 - being the median of BDNF in CDR3 (23.37 pg/mL) lower than in CDR1 (30.17 pg/mL) subgroup. BP group had lower levels of BDNF compared to CDR3 subgroup. BP patients when stratified with dementia, other ND and without ND, those with association with dementia presented the lowest levels of BDNF (9.1 pg/mL) compared to the PB patients without DN and to the CDR3 subgroup. Conclusion: BP biomarkers are not useful for the diagnosis of dementia. Low BDNF levels seen in BP patients may suggest an association with dementia. BDNF may be used as a biomarker of severity of dementia.

Submitted by Mario BC (mario@bc.ufrpe.br) on 2016-06-07T14:07:30Z No. of bitstreams: 1 Juceli de Souza Oliveira.pdf: 1137843 bytes, checksum: 9a49dc75826e1357551a46adec897f65 (MD5) / Made available in DSpace on 2016-06-07T14:07:30Z (GMT). No. of bitstreams: 1 Juceli de Souza Oliveira.pdf: 1137843 bytes, checksum: 9a49dc75826e1357551a46adec897f65 (MD5) Previous issue date: 2014-02-26 / In cattle, diseases of the central nervous system (CNS) cause serious economic losses, owing to the high mortality of animals that these diseases cause. Considering that Brazil is the largest beef exporters, it is necessary to strengthen the epidemiological surveillance of SCN diseases, performing the differential diagnosis of encephalitis and encephalopathy to provide epidemiological information to agriculture defense agencies and the National Rabies Control Program and Other Brain Diseases (PNCRH). Bovine herpesvirus 5 (BoHV-5), the causative agent of bovine herpetic meningoencephalitis is one of the most important agents to be included. The objective of this work is to review the main neurological diseases of cattle in northeastern Brazil and report the occurrence of cases of necrotizing meningoencephalitis associated BoHV-5, between the years 2011-2012, in the state of Pernambuco. The clinical signs consisted of circling, blindness, nasal and ocular discharge, head pressing, muscle tremors, incoordination, and permanent lateral recumbence followed by death. At necropsy no significant changes were observed. After cutting the brain previously fixed in formaldehyde solution, softened grayish areas of granular appearance and cavitations in the cerebral cortex, midbrain, hippocampus, thalamus, basal ganglia and cerebellum were observed. Microscopically there was nonsuppurative meningitis and diffuse encephalitis with perivascular cuffs, mononuclear or undifferentiated cells and neuronal necrosis. In areas of polioencefalomalacia there was neuronophagia and the presence of Gitter cells. In the samples submitted to PCR there was amplification of DNA from BoHV-5. / Em bovinos, as doenças do sistema nervoso central (SNC) provocam sérios prejuízos econômicos, tendo em vista a elevada mortalidade de animais que provocam. Considerando que o Brasil situa-se entre os maiores exportadores de carne bovina, torna-se necessário o fortalecimento do sistema de vigilância epidemiológica das doenças do SCN, realizando o diagnóstico diferencial das encefalites e encefalopatias a fim de fornecer informações epidemiológicas para os órgãos de defesa agropecuária e ao Programa Nacional de Controle da Raiva dos Herbívoros e Outras Encefalopatias (PNCRH). Dentre os agentes a serem incluídos, destaca-se os herpesvírus bovino 5 (BoHV-5), agente causador da meningoencefalite herpética bovina. O objetivo dessa dissertação é revisar as principais doenças neurológicas de bovinos no nordeste do Brasil e relatar a ocorrência em duas propriedades rurais no Estado de Pernambuco, de casos de meningoencefalite necrosante associada BoHV-5, que resultou na morte de 5 bovinos entre os anos de 2011-2012. Os sinais clínicos observados consistiram em andar em círculos, cegueira, pressão da cabeça contra objetos, tremores musculares, incoordenação, depressão acentuada e decúbito lateral permanente seguido de morte. À necropsia não foram observadas alterações significativas. Ao corte do encéfalo, após a fixação em formol, foram observadas áreas de aspecto granular ao corte, com coloração acinzentada, amolecidas e cavitações no córtex cerebral, mesencéfalo, hipocampo, tálamo, núcleos da base e cerebelo. Microscopicamente havia meningite não supurativa e encefalite difusa com a presença de manguitos perivasculares, de células mononucleares indiferenciadas e necrose neuronal. Nas áreas de polioencefalomalacia havia neuronofagia e a presença de células Gitter. Nas amostras submetidas à PCR houve amplificação do DNA de BoHV-5.

abstract: Speech is known to serve as an early indicator of neurological decline, particularly in motor diseases. There is significant interest in developing automated, objective signal analytics that detect clinically-relevant changes and in evaluating these algorithms against the existing gold-standard: perceptual evaluation by trained speech and language pathologists. Hypernasality, the result of poor control of the velopharyngeal flap---the soft palate regulating airflow between the oral and nasal cavities---is one such speech symptom of interest, as precise velopharyngeal control is difficult to achieve under neuromuscular disorders. However, a host of co-modulating variables give hypernasal speech a complex and highly variable acoustic signature, making it difficult for skilled clinicians to assess and for automated systems to evaluate. Previous work in rating hypernasality from speech relies on either engineered features based on statistical signal processing or machine learning models trained end-to-end on clinical ratings of disordered speech examples. Engineered features often fail to capture the complex acoustic patterns associated with hypernasality, while end-to-end methods tend to overfit to the small datasets on which they are trained. In this thesis, I present a set of acoustic features, models, and strategies for characterizing hypernasality in dysarthric speech that split the difference between these two approaches, with the aim of capturing the complex perceptual character of hypernasality without overfitting to the small datasets available. The features are based on acoustic models trained on a large corpus of healthy speech, integrating expert knowledge to capture known perceptual characteristics of hypernasal speech. They are then used in relatively simple linear models to predict clinician hypernasality scores. These simple models are robust, generalizing across diseases and outperforming comprehensive set of baselines in accuracy and correlation. This novel approach represents a new state-of-the-art in objective hypernasality assessment. / Dissertation/Thesis / Masters Thesis Electrical Engineering 2020

Stroke is serious neurological disease and is a major cause of death as well as disability throughout the globe. Stroke has a complex pathophysiology that involves inflammatory pathways, excitotoxicity mechanisms, oxidative damage, apoptosis, ionic imbalances, angiogenesis and neuroprotection. 85% of strokes are ischemic and occurs when a cerebral vessel, or any vessel supplying the brain, narrows or loses pressure resulting in subsequent brain ischemia and infarction downstream to the site of obstruction depriving tissues of vital oxygen and nutrients. This may be caused by either atherosclerotic thrombi or distant emboli defined as a mass of clotted blood or other material. It is estimated that over a billion people currently smoke cigarettes or use other tobacco products, seeing as smoking is a major risk factor for stroke this is of major concern. Platelets are hematopoietic cells produced by bone marrow megakaryocytes. Platelets play a role in the development of ischemic stroke primarily by means of their participation in the formation of thromboemboli, the presence of abnormal platelet function may predispose patients to a pro-thrombotic, pro-inflammatory state. The reorganization of the cytoskeleton in platelets is an important factor in the complex mechanisms found in thrombosis and haemostasis. The platelet membrane contains a large number of receptors which specifically bind agonists that stimulate the physiological platelet response. Oxidative stress is one of the mechanisms involved in the neuronal damage of stroke. Oxidative stress is a state of imbalance between free radical production, in particular, reactive oxygen species (ROS), and the ability of the organism to neutralize them, leading to progressive oxidative damage. Smoking is known to result in the generation of various free radicals. Flow cytometric analysis of the platelets of thrombo-embolic ischemic stroke patients and smokers revealed that the membranes of the two groups were altered in some form as well as an increased activation in both groups when compared to healthy individuals. Superoxide levels in the platelets were higher in smokers when compared to stroke patients, while hydrogen peroxide levels were elevated in the platelets of both groups. Superoxide was elevated in the whole blood samples of both groups. The production and subsequent reactions of reactive oxygen species appear to be influential in stroke and smoking and may likely be a crucial factor in the development of a pro-thrombotic, pro-inflammatory state which may prove to be a hallmark in the pathophysiology of stroke and smoking. Confocal microscopy and Scanning electron microscopy showed that platelets of stroke patients and smokers appear to be more activated and more prone to form tight clots. Furthermore an increased amount of superoxide is present in the platelets of stroke patients and smokers, specifically in the centre of clots. This may be an indication that once platelets have aggregated and started to fuse together, the mitochondria are expelled from the platelets and “trapped” within the clot. Atomic force microscopy also indicated both the stroke patients and smoker‟s platelets appear to be in a more activated state than the control group. Here it is apparent that some form of cytoskeletal rearrangement takes place to a more severe extent in the stroke group than in the smokers. Necrosis may be present in the platelets of stroke patients while neither apoptosis nor necrosis can be identified in the platelets of smokers however some form of membrane alteration is likely present. All the techniques used showed an increase in platelet activation in stroke patients and smokers, necrotic platelets may be present in the stroke patients while the platelet membrane of smokers seems to be altered. ROS is present and alters the platelet function of smokers and stroke patients in some way. It appears as if thrombo-embolic ischemic stroke patients and smokers‟ platelets have similar trends in activation but the processes involved to achieve this differ as there are structural differences present. These differences may prove a useful tool to further understand the pathophysiology behind thrombo-embolic ischemic stroke as well as to discover new therapeutic pathways. / Dissertation (MSc)--University of Pretoria, 2013. / gm2014 / Physiology / Unrestricted

No description available.

La discipline neurologique met en présence des soignants sains et des patients frappés de handicaps extrêmes auxquels le progrès médico-technique, fondé au XVIIe sur la mathématisation de la nature et le modèle du « corps-machine », n’a pas mis de terme. Comment se représenter l’aphasie, l’anosognosie, les altérations motrices et sensorielles chez autrui ? On se réfèrera aux travaux de Husserl et aux phénoménologues du corps pour approcher le mystère du vécu de la chair dans la maladie neurologique autrement que la sémiologie conventionnelle l’enseigne. Ce contact bouleversant avec les grands cérébrolésés n’est pas exempt d’intérêt, voire de jouissance : le spectacle du dépouillement humain par la perte du langage, du mouvement ou d’autres attributs, pourrait, dans un effet de miroir, et par une « association accouplante », permettre au témoin ici neurologue de se démonter lui-même et tendre vers l’élucidation de sa propre chair. Mais le système nerveux, par quoi la douleur ou le plaisir se manifestent à la conscience et au corps, qui afflige en même tant qu’il est affligé, est condamné à la forclusion du fait de son rôle nécessaire de médiateur physiologique. L’exclusivité d’une visée intentionnelle, dénoncée par Michel Henry, soutenue et entretenue par l’essor hégémonique de l’imagerie médicale, semble manquer ici la souffrance insoluble dans la donation extatique. Ce travail qui proposait, dans une démarche critique, de revisiter les soubassements du savoir neurologique, nous conduit vers une aporie : quelle est la phénoménologie du handicap neurologique s’il ne s’écrit ni ne se lit en termes positifs ? Devant l’insuffisance du logos à dire les altérations du monde et des vécus de la chair, s’invitent la réserve puis la métaphore artistique. C’est spécifiquement le travail du peintre Simon Hantaï qui ouvrira une voie entre phénomène mondain et incarnation. Il s’agira avec lui, dans un renoncement au savoir totalisant, d’apprendre à mettre en perspective les données des neurosciences et, ce que ni la science ni l’empathie pour autrui ne peuvent expliciter. Nous suggèrerons d’intégrer à la pratique médicale neurologique une démarche éthique autrement appelée « sagesse des limites » ; limites entre les savoirs, dont la figure toujours complexe, instable et miroitante, n’est pas sans évoquer une dimension baroque de la neurologie. / [Summary made by Reverso] The neurological discipline puts in the presence of nursing healthy and patients struck by extreme handicaps in which the medical technical progress, based(established) in the XVIIth on the mathématisation of the nature and the model of the "body-machine", did not put term. How to represent itself the aphasia, the anosognosie, the driving and sensory changes to others? We shall refer to the works of Husserl and to the phénoménologues of the body to approach the mystery of the real-life experience of the flesh in the neurological disease otherwise than the conventional semiology teaches him(it). This contact upsetting with the cérébrolésés big is not exempt from interest, even from enjoyment: the show(entertainment) of the human perusal by the loss of the language, the movement or the other attributes, could, in an effect of mirror, and by an accouplante " association ", allow the witness(baton) here neurologist to get confused itself and to aim towards the clarification of its own flesh. But the nervous system, by which the pain or the pleasure show themselves in the consciousness and in the body, which saddens even so much that it is saddened, is condemned to the debarment because of its necessary role of physiological mediator. The exclusivity of a deliberate aim, denounced(cancelled) by Michel Henry, supported and maintained by the hegemonic development of the medical imaging, seems to miss here the insoluble suffering in the ecstatic donation. This work which suggested, in a critical approach(initiative), revisiting the bases of the neurological knowledge, leads(drives) us towards an aporia: what is the phenomenology of the neurological handicap if he does not spell nor is read in positive terms? In front of the insufficiency of logos to say the changes of the world and the real-life experiences of the flesh, invite each other the reserve then the artistic metaphor. It is specifically the work of the painter Simon Hantaï that will open a way between worldly phenomenon and embodiment. It will be a question with him, in a renunciation of the adding up knowledge, of learning to put in perspective the data of the neurosciences and, what neither the science nor the empathy for others can clarify. We shall suggest to integrate(join) into the neurological medical practice an ethical otherwise called approach(initiative) " wisdom of the limits "; limits between the knowledges, the face(figure) of which always complex, unstable and gleaming, is not without evoking a baroque dimension(size) of the neurology.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Bovine herpesvirus types 1 and 5 (BoHV-1, BoHV-5) are genetically and antigenic related viruses and have been associated with important economic losses to the cattle industry. The aim of this Thesis was to perform the molecular identification of BoHV-1 and BoHV-5 isolates. The first part describes the identification of 40 herpesviruses isolated from different clinical specimens and syndromes in central-southern Brazil, Argentina and Uruguay (1987 2006). The differentiation between BoHV-1 and BoHV-5 was performed by examining the size of the amplification product of a glycoprotein C gene-based PCR, designed for a low homology region of the gene. BoHV-1 isolates (n=16) were identified in cases of respiratory disease (n=3), vulvovaginitis and/or balanoposthitis (n=3), in semen of healthy bulls (n=5) and in cases of neurological disease (n=5). Samples identified as BoHV-5 (n=24) were isolated predominantly from cases of neurological disease (n=21), but also from semen of healthy bulls (n=2) and from a spleen of a calf with systemic disease (n=1). These results show that both BoHV-1 and BoHV-5 are not strictly associated with their respective diseases; yet are frequently involved in clinical conditions otherwise attributed to the other virus type. These findings also reinforce the need of correctly identifying the herpesvirus isolates as to better understand their pathogenesis and epidemiology. In the second part, it is reported the characterization of five Brazilian BoHV-1 isolates associated with neurological disease, an unusual finding. All five samples were isolated from the brain of cattle presenting neurological disease, yet histological evidences of meningoencephalitis were not observed in three cases. The isolated viruses were identified as BoHV-1 by a glycoprotein C gene-based PCR able to differentiate BoHV-1 from BoHV-5. The identity of the isolates was confirmed by nucleotide sequencing of the amplicons and by restriction analysis of PCR products from another gC region. Monoclonal antibody binding and cross-neutralization assays with BoHV-1 and BoHV-5 antisera showed a typical BoHV-1 antigenic profile. Inoculation of rabbits with these five BoHV-1 isolates did not result in neurological disease, contrasting with fatal meningoencephalitis produced by BoHV-5. Thus, the involvement of BoHV-1 in neurological disease of cattle is more frequent than previously reported, indicating the need for fast and precise means of differentiating it from BoHV-5. Likewise, the potential role of BoHV-1 in neurological disease in cattle should be further investigated. / Os herpesvírus bovino tipos 1 e 5 (BoHV-1, BoHV-5) são agentes geneticamente e antigenicamente relacionados que causam grandes prejuízos econômicos à bovinocultura. O objetivo desta tese foi o de realizar a identificação e diferenciação molecular de isolados de BoHV-1 e BoHV-5. Na primeira parte, foi relatada a identificação de 40 amostras de BoHV isoladas de diferentes casos clínicos na região Centro-Sul do Brasil, Argentina e Uruguai entre 1987 e 2006. A diferenciação entre BoHV-1 e BoHV-5 foi realizada pelo uso de um PCR para uma região de baixa homologia do gene da glicoproteína C, o que permitiu a diferenciação entre os tipos virais pelo tamanho do amplicon. As amostras identificadas como BoHV-1 (n=16) foram isoladas de doença respiratória (n=3), balanopostite e/ou vulvovaginite (n=3), do sêmen de touros saudáveis (n=5) e de casos doença neurológica (n=5). As amostras identificadas como BoHV-5 (n=24) foram, em sua maioria, isoladas de doença neurológica (n=21), mas também do sêmen de touros saudáveis (n=2) e do baço de um bezerro com doença sistêmica (n=1). Esses resultados demonstram que tanto o BoHV-1 como o BoHV-5 não estão estritamente associados às suas respectivas síndromes clínicas e que podem estar envolvidos em casos clínicos classicamente atribuídos ao outro tipo viral. Esses achados também reforçam a necessidade da correta identificação dos isolados de herpesvírus para um melhor conhecimento da sua patogenia e epidemiologia. Na segunda parte do trabalho, foram caracterizados cinco isolados de BoHV-1 provenientes de casos de doença neurológica. Esses vírus foram isolados do encéfalo de bovinos que apresentavam sinais neurológicos. Entretanto, evidências histológicas de meningoencefalite não foram observadas em três dos cinco casos. Os isolados foram identificados como BoHV-1 pela utilização de um PCR direcionado para o gene da gC. A identidade dos isolados foi confirmada pelo sequenciamento do amplicon e também por um segundo PCR para outra região do gene da gC, seguido de análise de restrição enzimática do amplicon. A caracterização antigênica com anticorpos monoclonais e testes de soroneutralização cruzada demostraram um perfil típico de BoHV-1. Esses cinco isolados também foram inoculados em coelhos, nos quais não produziram doença neurológica. Esses resultados demostram que o envolvimento de BoHV-1 em doença neurológica em bovinos é mais frequente do que o relatado anteriormente, evidenciando a necessidade de uma precisa diferenciação entre os tipos virais.